| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |